LONDON BROKER RATINGS: Citi ups Admiral; Peel Hunt cuts Sabre
(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday: Read More
| Price | 12,940.00p on 28-07-2026 at 18:35:07 |
|---|---|
| Change | 52.00p 0.4% |
| Buy | 12,968.00p |
| Sell | 12,964.00p |
| Last Trade: | Unknown 0.00 at 12,883.93934p |
| Day's Volume: | 2,837,222 |
| Last Close: | 12,940.00p |
| Open: | 12,700.00p |
| ISIN: | GB0009895292 |
| Day's Range | 12,578.00p - 13,114.00p |
| 52wk Range: | 10,784.00p - 15,730.00p |
| Market Capitalisation: | £200.68b |
| VWAP: | 12,895.33519p |
| Shares in Issue: | 1.55b |
Astrazeneca (AZN) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Unknown* | 0 | 12,883.93934p | SI Trade Currency Conversion |
19:04:37 - 28-Jul-26 |
| Unknown* | 0 | 12,871.91022p | Currency Conversion OTC Trade |
19:03:36 - 28-Jul-26 |
| Unknown* | 0 | 12,869.65476p | Currency Conversion OTC Trade |
19:01:42 - 28-Jul-26 |
| Unknown* | 0 | 12,869.65476p | Currency Conversion OTC Trade |
19:01:42 - 28-Jul-26 |
| Unknown* | 1 | 12,883.93934p | SI Trade Currency Conversion |
18:56:18 - 28-Jul-26 |
| Unknown* | 10 | 12,883.18752p | Currency Conversion Negotiated Trade OTC Trade |
18:51:22 - 28-Jul-26 |
| Unknown* | 0 | 12,865.89566p | SI Trade Currency Conversion |
18:47:17 - 28-Jul-26 |
| Unknown* | 0 | 12,873.41386p | Currency Conversion OTC Trade |
18:43:10 - 28-Jul-26 |
| Unknown* | 0 | 12,873.41386p | Currency Conversion OTC Trade |
18:43:10 - 28-Jul-26 |
| Unknown* | 0 | 12,873.41386p | Currency Conversion OTC Trade |
18:43:10 - 28-Jul-26 |
Astrazeneca (AZN) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 27th Jul 2026 7:10 am | RNS | Update on Ultomiris Phase III trial in HSCT-TMA |
| 27th Jul 2026 7:05 am | RNS | Sone-Ve improved survival in gastric cancers |
| 27th Jul 2026 7:00 am | RNS | Half-year Financial Report |
| 23rd Jul 2026 7:00 am | RNS | Etcamah approved in the EU for ER+ breast cancer |
| 14th Jul 2026 7:00 am | RNS | AstraZeneca licenses novel EGFR inhibitor |
| 9th Jul 2026 7:00 am | RNS | Update on CARDIO-TTRansform Phase III trial |
| 1st Jul 2026 3:05 pm | RNS | Admission of Further Securities to Trading |
| 1st Jul 2026 3:00 pm | RNS | Total Voting Rights |
| 29th Jun 2026 7:30 am | RNS | Enhertu approved in EU for HER2+ solid tumours |
| 29th Jun 2026 7:00 am | RNS | Datroway recommended for approval in EU for TNBC |